(Q44018063)

29 November 2017

title

HLA determinants of susceptibility to multiple sclerosis in an Arabian Gulf population (English)

1 reference

29 November 2017

S Al-Shammri

1

1 reference

29 November 2017

R F Nelson

series ordinal

2

1 reference

29 November 2017

I Al-Muzairi

series ordinal

3

1 reference

29 November 2017

A O Akanji

series ordinal

4

1 reference

29 November 2017

publication date

1 August 2004

1 reference

Multiple Sclerosis Journal

29 November 2017

published in

1 reference

29 November 2017

volume

10

1 reference

29 November 2017

issue

4

1 reference

29 November 2017

page(s)

381-386

1 reference

The role of genetic factors in multiple sclerosis susceptibility.

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

Epidemiology of multiple sclerosis in Arabs in Kuwait: a comparative study between Kuwaitis and Palestinians

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and North Europeans

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

HLA class II (DRB1, DQA1 and DQB1) associated genetic susceptibility in Iranian multiple sclerosis (MS) patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

The prevalence of multiple sclerosis in the world: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

Association and linkage of juvenile MS with HLA-DR2(15) in Russians

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

Human leukocyte antigen studies in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

HLA-DR and -DQ associations with multiple sclerosis in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

HLA genotypes and disease severity assessed by magnetic resonance imaging findings in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

The HLA system. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

Progress in deciphering the genetics of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

Multiple sclerosis and the HLA-D region: linkage and association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458504MS1065OA

10.1191/1352458504MS1065OA

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference